US Stock MarketDetailed Quotes

BIVI BioVie

Watchlist

0.485
-0.004-0.84%

Close Apr 26 16:00 ET

26.63MMarket Cap-414P/E (TTM)

BioVie Stock Forum

151675461

Apr 25 03:44

Maybe 0.6 at the end?

$BioVie(BIVI.US)$

Jaguar8

Apr 18 20:21

$BioVie(BIVI.US)$
NEWS
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary BioVie Inc. (Nasdaq: BIVI) announced the approval of the non-proprietary name 'bezisterim' for NE3107, a potential treatment for neurological disorders. The company will present data at the 12th Annual Alzheimer's & Parkinson's Drug Development S...

Golden Government _1

Apr 12 21:43

$BioVie(BIVI.US)$ BIV201 Phase 3 is pending funds from “undisclosed yet partner” , partner is dragging their feet and not in a hurry to cut the check due economy , covid and ukraine bull. Especially if that undisclosed yet partner is looking to buy out Biovie , thus intrested to buy BIVI shares at cheap.
The good news will be in “middle of summer 2024” or earlier , when partnership and BIV201 Phase 3 funding will be announced

Powdahound

Apr 12 11:00

$BioVie(BIVI.US)$ 🔥🔥🔥🔥🔥🔥

Becky007

Apr 4 00:46

$BioVie(BIVI.US)$ Holding @ 1.3. When is the next PR? Its in pathetic state seriously….

Dragana

Mar 7 06:01

$BioVie(BIVI.US)$ BUG BIG news, there finished the second stage of testing(which worked) for a new drug that helps with Parkinson's and dementia, they have 1 more test and if it works they will go NUCLEAR!!! ☘️💪🔥😇🙏

Dakota97

Mar 6 06:30

$BioVie (BIVI.US)$ This stock is looking like it's not going to come back up anytime soon

Stock Region

Mar 5 00:06

Medical Company Presents Promising New Hope For Parkinson's & Alzheimer's Patients

BioVie's NE3107: A New Hope for Parkinson's and Alzheimer's Patients.
In the realm of neurodegenerative disease research, significant strides are being made. One such stride is the development of BioVie Inc.'s drug NE3107, which has shown promising preliminary results in treating both motor and non-motor symptoms for Parkinson's patients. The data is set to be presented at the International Conference on Alzheimer'...